10-QPeriod: Q2 FY2017

ECOLAB INC. Quarterly Report for Q2 Ended Jun 30, 2017

Filed August 3, 2017For Securities:ECL

Summary

Ecolab Inc. reported solid financial results for the second quarter and first six months of 2017, demonstrating growth in net sales and net income attributable to Ecolab compared to the prior year. Net sales increased by 4% to $3.5 billion in the second quarter and 3% to $6.6 billion for the first six months. Net income attributable to Ecolab rose by 15% to $296.6 million in the quarter and 12% to $550.1 million for the year-to-date period. The company's performance was bolstered by strength in its Global Industrial and Global Institutional segments, with notable contributions from its Water, Food & Beverage, Paper, and Healthcare businesses. Despite a decrease in adjusted gross margin due to higher delivered product costs and an unfavorable currency hedge impact, the company's SG&A expenses as a percentage of sales improved. Ecolab also announced new restructuring and cost-saving actions aimed at streamlining operations, which are expected to yield benefits in the latter half of the year. The company's acquisition of Anios in early 2017 contributed significantly to asset growth and is expected to expand its offerings in the hygiene and disinfection market. Overall, Ecolab demonstrated resilience and growth, managing costs effectively while investing in strategic initiatives.

Financial Highlights

54 data points
Beta

Revenue

$3.46B

41.2% Gross Margin

Net Income

$294.80M

8.5% Net Margin

EPS (Diluted)

$1.00

Total Assets

$19.52B

Cash & Equivalents

$260.70M

Free Cash Flow

$223.30M

Financial Statements
Beta
Revenue$3.46B
Cost of Revenue$2.04B
Gross Profit$1.43B
SG&A Expenses$967.00M
Operating Income$419.60M
Interest Expense$63.70M
Net Income$294.80M
EPS (Basic)$1.02
EPS (Diluted)$1.00
Shares Outstanding (Basic)289.80M
Shares Outstanding (Diluted)294.10M

Key Highlights

  • 1Net sales increased by 4% to $3.5 billion for the second quarter ended June 30, 2017, compared to $3.3 billion in the prior year.
  • 2Net income attributable to Ecolab rose 15% to $296.6 million in the second quarter, or $1.01 per diluted share, up from $0.87 per diluted share in the prior year.
  • 3The Anios acquisition, completed in February 2017 for $798.3 million, is integrated into the Global Institutional segment and is expected to expand Ecolab's healthcare market presence.
  • 4Special charges decreased significantly to $61.2 million in the second quarter of 2017, down from $88.1 million in the same period of 2016, primarily due to the absence of energy-related charges.
  • 5Selling, General, and Administrative (SG&A) expenses as a percentage of sales improved to 32.2% in the second quarter of 2017 from 33.0% in the prior year, indicating improved cost management.
  • 6The company announced restructuring and cost-saving actions in Q2 2017, including a global workforce reduction of approximately 530 positions, expected to result in charges of $40-45 million.
  • 7Ecolab's debt-to-EBITDA ratio improved to 2.6x at June 30, 2017, from 2.8x at the end of 2016, indicating a stronger leverage position.

Frequently Asked Questions

Sales growth in the second quarter of 2017 was primarily driven by solid performance in the Global Industrial and Global Institutional segments. The Water business within Global Industrial and the Specialty and Healthcare businesses within Global Institutional showed particular strength. Pricing and volume increases also contributed positively across several segments.

The acquisition of Anios in February 2017 for approximately $798.3 million contributed to an increase in total assets. It was integrated into the Global Institutional segment and is expected to expand Ecolab's product offerings and geographic footprint in the healthcare market. While the acquisition involved significant consideration and integration costs, it is part of Ecolab's strategy to enhance its position in hygiene and disinfection solutions.

The Global Energy segment showed a modest increase in fixed currency sales in Q2 2017, driven by strong growth in well stimulation business, partially offset by a decline in the production business. While the segment's results are subject to volatility in oil and gas commodity markets, management remains confident in its long-term growth prospects due to the company's global footprint, broad business portfolio, and strong execution capabilities. Lower oil prices are also expected to benefit other segments through reduced raw material costs.

Ecolab reported a decrease in its net debt to EBITDA ratio to 2.6x as of June 30, 2017, down from 2.8x at the end of 2016, indicating improved financial leverage. The company continues to generate strong operating cash flow, which it uses to fund operations, debt repayments, investments, acquisitions, and shareholder returns. Ecolab also has a substantial credit facility to support its liquidity needs.